openPR Logo
Press release

Prostate Cancer Diagnostics Market Supply and demand chain forecast 2018-2028 : MDx Health, Myriad Genetics, Inc., Abbott Laboratories, F. Hoffman-La Roche AG

01-07-2019 11:39 AM CET | Health & Medicine

Press release from: TMR Research

Prostate Cancer Diagnostics Market Supply and demand chain forecast 2018-2028 : MDx Health, Myriad Genetics, Inc., Abbott Laboratories, F. Hoffman-La Roche AG

Prostate Cancer Diagnostics Market: Snapshot

As the name suggests, prostate cancer occurs in the prostate area of men, which basically is a small gland shaped like a walnut, which produces seminal fluid that helps maintain sperms and facilitates their transportation. With rapidly increasing instances of this cancer recorded in recent times, a dire need for diagnosing it exists, followed by treatment, consequently giving rise to the prostate cancer diagnostic market.

Major symptoms of prostate cancer include trouble while urinating, blood in semen, reduction in the force of urine, bone pain, erectile dysfunction and many others. Early detection of prostate cancer is highly necessary so that chances of treating it completely could exist. Although no specific causes for this ailment are present, sedentary lifestyles, obesity, and genetic history are observed to be likely causes of prostate cancer. Thus, these are key factors that are essentially driving growth in the global prostate cancer diagnostics market.

The market is majorly restrained thanks to high costs of the diagnostic procedures. Moreover, quality diagnosis may be provided in remote and underdeveloped regions, consequently making it difficult for reducing mortality rate in these regions. In addition, complexities associated with prostate cancer diagnostics too poses as a key obstacle to the market’s progress. However, many players are expected to resolve such issues by improving efficiency of the diagnostic procedures, consequently offsetting most restraints.

The prostate cancer diagnostics market depicts the presence of a substantially competitive vendor landscape, mainly due to recent developments that deal with improving quality of diagnosis and treatment provided. Most players are focusing on improving their geographical extent as well as reduction of diagnostic procedure costs too, so that those affected belonging to different economic categories can avail the relevant services. With the number of players expected to increase in the market, the competition is likely to intensify in the near future.

Request Sample Copy of the Report @

www.tmrresearch.com/sample/sample?flag=B&rep_id=3897

Prostate Cancer Diagnostics Market: Overview

Sudden uncontrolled growth of cells in prostate organ provokes the advancement of prostate cancer. Various men suffer from poor-grade prostatic intraepithelial neoplasia (PIN), but do not get prostate cancer. For now, there is no sure method to prevent the causing of the cancer, nevertheless, the odds can be brought down by keep a healthy diet and being physically active.

On the basis of type, the global prostate cancer diagnostics market is categorized into confirmatory tests and preliminary tests. Among these, confirmatory tests are sub-divided as trans-rectal ultrasound, Prostate Cancer Antigen (PCA3) test, and biopsy. The preliminary tests accounted for major share in prostate cancer diagnostics market, back in 2016. Along with the physical diagnosis, tests used for the detection of prostate cancer are Digital Rectal Exam (DRE), Prostate-specific Antigen (PSA) test, and Biomarker tests.

Request TOC of the Report @

www.tmrresearch.com/sample/sample?flag=T&rep_id=3897

Prostate Cancer Diagnostics Market: Trends and Opportunities

Prostate cancer diagnostics market is majorly determined by a couple of key factors, for example, growing popularity of serum based marker testing for detection of prostate cancer, rise in awareness about increase in health issues, prevention of disease, and improved research for recognition of different sorts of cancers. Moreover, the prostate cancer screening market is experiencing a notable development because of the various public awareness campaign and different government activities. Organizations are taking a shot at manufacturing technologically advanced products for early prostate cancer recognition and these elements are driving the development of the prostate cancer screening market. Along with these factors, the firms expect to witness a reduction in number of people dying, once the new tests are launched in the market for prostate cancer.

Nevertheless, there are certain factors that are estimated to hinder the entire market growth. Some of the challenges faced by the market are, high expenditure to detect the disease in early stage and performing unrequired screening and biopsies, danger of over-analysis and overtreatment, reactions of medical procedure like impotence and urinary incontinence, MRI scans are usually precise, but much time taking and expensive for patients. Prostate cancer diagnostics tests are expensive which a major drawback for the market.

Read Comprehensive Overview of Report @

www.tmrresearch.com/prostate-cancer-diagnostics-market

Prostate Cancer Diagnostics Market: Regional Outlook

Geographically, North America region is the main market, trailed by Europe. Advancement in technology, launch of innovative products, improved healthcare facilities are some of the factors helping in the development of the mentioned market. The U.S., specifically, is the biggest market for prostate cancer diagnostics all over the world. These tests are being adopted widely in the nation owing to rise in prevalence of illness and supporting government activities.

Asia Pacific is foreseen to show the most elevated CAGR during the forecast period owing to the emergence of several untapped opportunities in the developing economies, for example, China and India. Moreover, socio-cultural changes and steady economic development in the mentioned region have stimulated a westernized way of life bringing about the rise in prevalence of various illnesses. The demand for prostate cancer diagnostics is high in the Asian nations, for example, China and Japan.

Apart from this, the factors, such as, presence of key players in the developing nations of Asia Pacific, and rise in awareness with respect to the illness are in charge of market development in in the region. Moreover, spending on healthcare has also increased which has propelled the adoption advanced products in nations, for example, India and China, that is estimated to help in regional market development.

Prostate Cancer Diagnostics Market: Competitive Scenario

The key players operating in the global market include MDx Health, Myriad Genetics, Inc., Abbott Laboratories, F. Hoffman-La Roche AG, Genomic Health, Siemens Healthcare GmbH, and OPKO Health, Inc.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Cancer Diagnostics Market Supply and demand chain forecast 2018-2028 : MDx Health, Myriad Genetics, Inc., Abbott Laboratories, F. Hoffman-La Roche AG here

News-ID: 1474850 • Views: 135

More Releases from TMR Research

Weigh in Motion Market Share and Growth Factors Impact Analysis 2018 – 2028
Weigh in Motion Market – Introduction Weigh in motion (WIM) devices are specifically designed equipment to record the truck axle & gross vehicle weights as they drive over a measuring site or a sensor. The existing weigh in motion systems are witnessing an increasing traction over the conventional static weigh stations, as they don’t require the vehicle to stop, which make them a more efficient option. Numerous benefits of weigh
Gas Analysis Systems Market Competitive Landscape Analysis with Forecast by 2028
Gas Analysis Systems Market Introduction Gas analysis systems are used to monitor or analyze various chemical gases present in the product or sample. It helps in identifying the gas and also provides information on the quantity, displaying in the numerical or graphical form. The standard gas analysis system includes sample probe, line, filter, gas conditioning system including pump, cooler, and calibration gas system, and series of gas analyzers. Industries across sectors
VRF System Market - Product Application 2028 | Commercial Residential Others (Me …
VRF System Market – Introduction Variable refrigerant flow (VRF) system is widely adopted to control the amount of refrigerant flowing to various evaporators with different configurations and capacities. This growing adoption of VRF systems is attributed to their ability to provide comfort without swings at room temperature by offering the desired supply of heating or cooling when the need arises. VRF system caters to various applications owing to its availability
Digital Out of Home Market Dynamic Business Environment during 2018 - 2028
Digital Out of Home Market– Introduction Digital out of home (DOOH), also referred to as digital signage is a modern form of advertising that has effectively replaced traditional forms of advertising and marketing. Digital out of home advertising enables local vendors and advertisers to engage customers in real time, and track and monitor the effectiveness of their marketing messages. DOOH is a rapidly growing and dynamically-served visual mode of advertising

All 25823 Releases


More Releases for Prostate Cancer Diagnostics

Prostate Cancer Molecular Diagnostics Market Size, Share | Industry Report 2025
The global prostate cancer molecular diagnostics market was valued at $212.4 Million in 2017 and is forecast to grow at a modest 15.4 % CAGR between 2018 and 2025, culminating in 2025 global sales of $630.4 Million. Individualized and targeted treatments are reshaping oncology. Key to personalized medicine lies in molecular pathology. Use of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many
Prostate Cancer Diagnostics Market Intelligence Report Offers Growth Prospects
An increasing geriatric population across the developed world along with access to top-quality healthcare is expected to benefit the prostate cancer diagnostics market. Healthcare spending is growing by leaps and bounds both though the government as well as private providers. As per the WHO Health Spending Observatory, the spending on health may rise to US$ 18.2 trillion by the year 2040 with annual growth rates of 3.4% in upper middle
Prostate Cancer Therapeutics Market: Future Perspective Growth In Prostate Cance …
Global Prostate Cancer Therapeutics Market Precision Business Insights (PBI) in its report titled “Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Prostate Cancer Therapeutics Market Prostate is an exocrine
Prostate Cancer Diagnostics Market 2017 - OPKO, Abbott, Roche, DiaSorin, bioMeri …
Apex Research, recently published a detailed market research study focused on the "Prostate Cancer Diagnostics Market" across the global, regional and country level. The report provides 360° analysis of "Prostate Cancer Diagnostics Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Prostate Cancer Diagnostics industry, and estimates the future trend of Prostate